A Highlight of Provincial-Level Special Project Presentation! Oukebaike Broad-Spectrum Antibacterial Probiotics Lead a New Direction in Antibiotic-Free Farming
Times:2025-12-08 08:51:00
From:Okobake
Recently, Yang Xiaojin, Biotechnology Director of Oukebio, and Dr. Li Wang, Technical Expert, were invited to participate in the video conference defense of the Henan Provincial Key Research and Development Project (Agriculture and Rural Areas). Their professional presentation of the project, "Development and Industrialization of Broad-Spectrum Antibacterial Probiotic Preparations," garnered high attention from the review experts. This project focuses on "healthy livestock and poultry farming and disease prevention," responding to the "antibiotic reduction and replacement" policy through technological innovation and injecting new momentum into the green transformation of the livestock industry.
As a high-tech enterprise, Oukebio has deep expertise in the field of functional probiotics, possessing two provincial-level platforms: the Henan Provincial Engineering Technology Research Center for Feed Microbial Development and the Henan Provincial Engineering Research Center for Feed Microecological Preparations. It has been granted 50 patents. This project was led by Director Yang Xiaojin, who collaborated with professors from Henan University of Science and Technology and Henan Agricultural University to form the core R&D team, leveraging their solid professional backgrounds to ensure the project's success.
Currently, the livestock industry faces problems such as the spread of drug-resistant bacteria and product residues due to antibiotic overuse. Domestic antibacterial probiotic preparations generally suffer from narrow antibacterial spectra and poor stability. Okobio targets industry pain points, achieving technological breakthroughs in high viable cell counts and strong stability in its products through multi-dimensional strain screening and optimization of fermentation and drying processes. This allows for targeted treatment of four common pathogenic bacteria, including E. coli and Salmonella, making it a superior alternative to antibiotics.
This participation in the provincial key R&D project defense is a concentrated demonstration of Okobio's technological strength. In the future, the company will continue to be driven by industry-academia-research collaborative innovation, accelerating the industrialization process of its projects, providing efficient microbial solutions for healthy livestock and poultry farming, and contributing to the green and sustainable development of agriculture!
Tags: